Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Grid system for a suspended ceiling
Modular nucleic acid-based circuits for counters, binary operations, memory and logic
Television system, television set and remote controller
Radiographic imaging method and apparatus
Telecommunications wire having a channeled dielectric insulator and methods for manufacturing the same
Memory device having three-dimensional gate structure
Semiconductor device and method of forming protective layer over exposed surfaces of semiconductor die
  Randomly Featured Patents
Per-value user notification throttling in a software application
Method and apparatus for improved speech recognition from stress-induced pronunciation variations with a neural network utilizing non-linear imaging characteristics
Migraine and vasodilation treatment
Device for double-acting hydraulic systems
Light emitting device, package, and system
Modular graft assembly
Solid state heterojunction and solid state sensitized photovoltaic cell
Pre-charging display apparatus
Exercise bike for rehabilitation
Heterogeneous alkoxylation using anion-bound metal oxides